secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cosmos Health Inc. (COSM)
CIK:        0001474167
Form:       8-K
Filed at:   2023-02-07T23:59:59+00:00
Accession:  0001477932-23-000799
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cosmos Health appoints Nikos Bardakis as COO; Pavlos Ignatiades moves to CCO
----------------------------------------------------------------------------

- Nikos Bardakis appointed COO effective Feb 1, 2023, with over 20 years international pharma experience.
- Bardakis previously National Sales Director at Servier Hellas, managing 130+ employees.
- Pavlos Ignatiades transitions from COO to Chief Communications Officer (CCO).
- Ignatiades had been COO since 2020, responsible for Nasdaq listing and investor relations.
- CEO Greg Siokas states moves support multi-layered growth strategy and transformation to healthcare company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223000799/0001477932-23-000799-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223000799/cosm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-000799

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer